Alkem Laboratories Ltd
Kevin Mehta has extensive experience in taxation and compliance, currently serving as a Manager at Alkem Laboratories Ltd. since January 2016, with a prior role as Assistant Manager focused on Indirect Taxation. Previous experience includes an internship at Fasttrack Financial Planners in mid-2015 and a managerial position at M. B. Mehta & Associates from September 2007 to July 2014, where responsibilities included TDS compliance and company law compliance. Kevin Mehta holds a MBA/PGDM in Finance from Garware Institute of Career Education and Development, a Diploma in Tax Management from Welingkar Institute of Management, an M.Com in Advanced Accounting from Mumbai University, and a B.Com in Commerce from SIES College of Commerce and Economics. Early education includes a Higher Secondary Certificate and Secondary School Certificate from SIES College and Don Bosco High School, respectively.
This person is not in any teams
This person is not in any offices
Alkem Laboratories Ltd
9 followers
Alkem Laboratories Limited is a pharmaceutical company. The Company is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products. The Company operates through two segments: pharmaceutical and investing. The Company produces generics, generic drugs, active pharmaceutical ingredients (APIs) and neutraceuticals, which it markets in India and approximately 50 countries internationally, primarily the United States. The Company offers various products, such as CLAVAM 375, CLAVAM BID DRY SYRUP, CLAVAM INJ 300MG, FREEAIR NASAL SPRAY, PAN 40MG INJECTION (VIAL), PAN/40MG TABLETS, PROWEL DRY SYRUP (30ML), TAXCLAV 100 DT TABLETS, SATROGYL O DRY SYRUP, XONE/500MG VAIL, MEROSURE KIT 500, MEROSURE 500 MG and ZADONASE, among others. The Company has approximately 16 manufacturing facilities, of which 14 manufacturing facilities are at geographically diversified locations in India and two in the United States.